{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-026971","form_type":"8-K","ticker":"BIAF","cik":"0001712762","company_name":"bioAffinity Technologies, Inc.","filed_at":"2025-09-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.753775+00:00","generated_at":"2026-05-17T07:19:24.531467+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"bioAffinity Technologies case study shows CyPath Lung detects cancer in ground-glass nodules","bullets":["Case study: 66-year-old former smoker with 13mm ground-glass nodule; CyPath Lung returned 'likely malignant' result.","Robotic bronchoscopy confirmed lung cancer after positive CyPath result; patient referred for surgical treatment.","Current guidelines recommend 2-5 years watchful waiting; CyPath may reduce diagnostic delay and uncertainty.","Company issued press release on September 9, 2025 highlighting real-world clinical utility of CyPath Lung."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-026971","json":"https://secwatch.observer/filing/0001641172-25-026971.json","markdown":"https://secwatch.observer/filing/0001641172-25-026971.md","text":"https://secwatch.observer/filing/0001641172-25-026971.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1712762/000164117225026971/0001641172-25-026971-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1712762/000164117225026971/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T07:19:24.531467+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}